Caspase-3 antibody | knockout validation | BD Biosciences 610323

This is a knockout-validated antibody summary, based on the publication "Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG2a

Company: BD Biosciences

Antibody: Caspase-3

Catalog number: 610323

Summary: Mouse monoclonal IgG2a against human CPP32 (aa. 1-219). Reacts with human protein by western blot, immunofluorescence, and immunoprecipitation. Not recommended for immunohistochemistry.

Validation Method

Western blot

Sample

Control, caspase-3 single knockout and caspase-3/7 double knockout cells.

Blocking agent

1% blocking reagent (Roche, Sydney, NSW, Australia) in PBS.

Primary incubation

1:1,000 dilution.

Secondary incubation

1:20,000 dilution horseradish peroxidase (HRP)-conjugated secondary antibodies in block buffer containing 1% Triton X-100.

Detection

SuperSignalWest Dura Extended Duration Substrate (Thermo Fisher Scientific, Vic, Australia).

Figure

Caspase-3, -7 and -8 protein expression in control, single knockout and double knockout cells was assessed by immunoblot. Probing for GAPDH was used to indicate loading. From [1].

References
  1. Miles M, Hawkins C. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death Dis. 2017;8:e3062 pubmed publisher